Dennis H. Langer's most recent trade in Quoin Pharmaceuticals Ltd - ADR was a trade of 21,709 Share Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quoin Pharma Ltd (ADR) | Dennis H. Langer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2026 | 21,709 | 21,709 | - | - | Share Option (Right to Buy) | |
| Quoin Pharma Ltd (ADR) | Dennis H. Langer | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 14 Oct 2025 | 15,152 | 15,152 | - | - | Series K Warrants (Right to Buy) | |
| Quoin Pharma Ltd (ADR) | Dennis H. Langer | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 14 Oct 2025 | 15,152 | 15,152 | - | - | Series J Warrants (Right to Buy) | |
| Quoin Pharma Ltd (ADR) | Dennis H. Langer | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 14 Oct 2025 | 15,152 | 15,152 | - | - | Series I Warrants (Right to Buy) | |
| Quoin Pharma Ltd (ADR) | Dennis H. Langer | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 14 Oct 2025 | 15,152 | 15,152 | - | - | Series H Warrants (Right to Buy) | |
| Quoin Pharma Ltd (ADR) | Dennis H. Langer | Director | Purchase of securities on an exchange or from another person at price $ 8.49 per share. | 14 Oct 2025 | 15,152 | 15,153 | - | 8.5 | 128,640 | ADSs |
| Quoin Pharma Ltd (ADR) | Dennis H. Langer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2025 | 13,682 | 13,682 | - | - | Share Option (Right to Buy) | |
| Quoin Pharma Ltd (ADR) | Dennis H. Langer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 7,760 | 7,760 | - | - | Share Option (Right to Buy) | |
| Quoin Pharma Ltd (ADR) | Dennis H. Langer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 50,714 | 50,714 | - | - | Share Option (Right to Buy) | |
| Quoin Pharma Ltd (ADR) | Dennis H. Langer | Director | Sale of securities on an exchange or to another person at price $ 0.73 per share. | 07 Jun 2024 | 297 | 53 | - | 0.7 | 217 | Ordinary Shares |
| Myriad Genetics Inc | Dennis H. Langer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 17,275 | 106,802 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics Inc | Dennis H. Langer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2021 | 30,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics Inc | Dennis H. Langer | Director | Sale of securities on an exchange or to another person at price $ 34.75 per share. | 03 Aug 2021 | 30,000 | 89,527 (0%) | 0% | 34.8 | 1,042,500 | Common Stock |
| Myriad Genetics Inc | Dennis H. Langer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.39 per share. | 03 Aug 2021 | 30,000 | 119,527 (0%) | 0% | 25.4 | 761,700 | Common Stock |
| Myriad Genetics Inc | Dennis H. Langer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 12,848 | 89,527 (0%) | 0% | 0 | Common Stock |